Ciguatera Poisoning: A Global Issue with Common Management Problems by Ting, Joseph Y. S. & Brown, A. F. T.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE, 2001, 8, 295300
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management problems
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Ciguatera poisoning, a toxinological syndrome comprising an enigmatic mixture of gastroin-
testinal, neurocutaneous and constitutional symptoms, is a common food-borne illness related
to contaminated fish consumption. As many as 50 000 cases worldwide are reported annually,
and the condition is endemic in tropical and subtropical regions of the Pacific Basin, Indian
Ocean and Caribbean. Isolated outbreaks occur sporadically but with increasing frequency in
temperate areas such as Europe and North America. Increase in travel between temperate
countries and endemic areas and importation of susceptible fish has led to its encroachment
into regions of the world where ciguatera has previously been rarely encountered. In the
developed world, ciguatera poses a public health threat due to delayed or missed diagnosis.
Ciguatera is frequently encountered in Australia. Sporadic cases are often misdiagnosed or not
medically attended to, leading to persistent or recurrent debilitating symptoms lasting months
to years. Without treatment, distinctive neurologic symptoms persist, occasionally being
mistaken for multiple sclerosis. Constitutional symptoms may be misdiagnosed as chronic
fatigue syndrome. A common source outbreak is easier to recognize and therefore notify to
public health organizations. We present a case series of four adult tourists who developed
ciguatera poisoning after consuming contaminated fish in Vanuatu. All responded well to
intravenous mannitol. This is in contrast to a fifth patient who developed symptoms suggestive
of ciguatoxicity in the same week as the index cases but actually had staphylococcal endocardi-
tis with bacteraemia. In addition to a lack of response to mannitol, clinical and laboratory
indices of sepsis were present in this patient. Apart from ciguatera, acute gastroenteritis
followed by neurological symptoms may be due to paralytic or neurotoxic shellfish poisoning,
scombroid and pufferfish toxicity, botulism, enterovirus 71, toxidromes and bacteraemia.
Clinical aspects of ciguatera toxicity, its pathophysiology, diagnostic difficulties and epidemi-
ology are discussed.
 2001 Lippincott Williams & Wilkins.
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INTRODUCTION
Ciguatera poisoning, a fish-borne toxinological syn-
drome comprising a mixture of gastrointestinal, neu-
rocutaneous and constitutional symptoms, is encoun-
tered frequently in the tropics and increasingly in
temperate regions of the world.1 6 The global dis-
tribution and risk stratification for ciguatera poison-
ing is seen in Fig. 1. It is a major obstacle to the safe
consumption of local and imported fish1 and is a
significant public health issue.7 Although many cases
have been recorded in Australia,8 scant public health
data exist regarding this condition due to under-de-
tection of sporadic cases and non-mandatory notifi-
cation.1 Even amongst the medical community,
ciguatera remains under-recognized.9 This lack of
To whom correspondence should be addressed
awareness leads to a delay in the diagnosis, notifica-
tion and treatment of ciguatera poisoning.10 Common
source outbreaks are easier to recognize, with four
cases of ciguatera poisoning presenting to our emer-
gency department in 1996. All had become sympto-
matic within 12 hours of eating contaminated coral
trout caught off Efate Island at a resort in Vanuatu. A
fifth subject with staphyloccocal bacteraemia was
misdiagnosed with ciguatoxicity in the same week.
Although ciguatoxicity has characteristic features, be-
ing alert to the possibility of other diagnoses even in
the presence of a prior history of ciguatera poisoning
is emphasized.
CLINICAL RECORD
Case 1
A 33-year-old man presented with peripheral para-
 2001 Lippincott Williams & Wilkins.
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( ) (Fig. 1. Global distribution of ciguatera, with areas of high-to-moderate risk heavy shading and low or uncertain risk lighter
) ( )shading identified. Reprinted from Lehane, L. and Lewis, R.J. 2000 Ciguatera: recent advances but the risk remains. Int. J.
Food Micro., 61, 91125, with permission from Elsevier Science.
doxical burning cold temperature sensitivity, circum-
oral and limb dysaesthesiae, myalgia, arthralgia,
lethargy and pruritus. The first symptom where cuta-
neous temperature perception is reversed is peculiar
to ciguatera poisoning. Four days previously he had
eaten freshly caught coral trout during a resort holi-
day in Vanuatu. Within hours, he developed nausea,
vomiting and diarrhoea followed by lower abdomi-
nal, testicular and penile pain. He described excruci-
ating discomfort during penile erection and after
ejaculation. He was fit and well apart from severe
visual impairment due to hereditary retinitis pigmen-
tosa.
The subject looked well and was apyrexial with nor-
mal vital observations and mental state. Mild lower
abdominal and genital discomfort was found on pal-
pation without peritonism. Neurological examination
was normal apart from a left afferent pupillary defect
and bilateral retinal pigmentation of retinitis pig-
mentosa.
All laboratory investigations were normal. A clinical
diagnosis of ciguatera poisoning was made and two
Žintravenous doses of 20% mannitol 0.5 gkg 2.5
.mlkg were infused over 30 minutes each, leading
to the rapid resolution of symptoms. We were told
that the patient’s previously well female partner, who
had not recently eaten any fish, experienced nausea,
circumoral dysaesthesia, arthralgia, lethargy and pru-
ritus within 24 hours of having unprotected vaginal
intercourse with him. She made an uneventful recov-
ery within a week without treatment.
Cases 2, 3 and 4
Three males aged 40, 43 and 48 years had similar
symptoms to those of the index case within 12 hours
of eating the same fish. In addition, one subject had
intense penile pain following defecation and another
penile pain including on erection. All had been previ-
ously fit and were well hydrated and without abnor-
mal physical or laboratory findings. Cases 2 and 4
responded well to two doses of 0.5 gkg of 20%
mannitol after presenting 6 and 8 days respectively
after exposure. Eight days after exposure, Case 3
experienced symptomatic improvement with a single
dose of mannitol although symptoms recurred a week
later. No subject had symptoms at 1-month follow-up.
Case 5
A 63-year-old man presented independently in the
same week as the previous cases, declaring that his
ciguatera poisoning was back. He had eaten frozen
fish bought at a supermarket in Brisbane. He then
developed myalgias, abdominal pain, nausea, vomit-
ing, diarrhoea, paraesthesiae, headache and fevers.
He believed these symptoms to be identical to those
experienced on two separate occasions, 6 and 20
years previously, when he had been diagnosed with
ciguatera poisoning.
He looked unwell with a temperature of 38C, had
moderate dehydration with poor skin turgor, pulse
100minute, blood pressure 10060 mmHg supine
with a small postural drop on sitting up. No clinical
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features of respiratory, genitourinary, gastrointesti-
nal, cardiac, joint, skin or ENT infection were present.
The patient was orientated to time, place and person
and demonstrated no meningism or rash. An up-
going left Babinski reflex was elicited with an other-
wise normal neurological examination.
On presentation, his white cell count was 6.83109l
Ž 9.2.07.510 with moderate left shift and neu-
trophil vacuolation. Platelet count was 72109l
Ž 9.14040010 with a haemoglobin of 13.1 gdl
Ž .13.518.0 . Abnormal serum electrolytes and liver
function tests included creatinine 0.15 mmoll
Ž . Ž .0.060.14 , total bilirubin 14 moll 020 , alkaline
Ž .phosphatase 36 ul 35140 , gamma glutamyltrans-
Ž .ferase 40 ul 050 , alanine aminotransferase 147
Ž . Ž .ul 035 , aspartate transaminase 181 ul 035
Ž .and creatine kinase 850 ul 30210 . Microscopy of
6 Žmid-stream urine revealed leukocytes 1010 l 
6. 6 Ž 6.1010 , erythrocytes 4010 l 1010 and
6 Ž 6.epithelial cells 1010 l 1010 . Culture
was not performed due to the absence of bacteria on
microscopy.
The patient and his wife were convinced of the diag-
nosis of ciguatera. Mannitol had been used with
success 6 years previously, and following intra-
venous rehydration with 1 litre of Hartmann’s solu-
tion, 0.5 gkg of 20% mannitol was administered
without symptomatic improvement.
Persistent fever and headache, a rising white cell
count with worsening thrombocytopenia and liver
function tests alerted us to the possibility of sepsis. A
chest X-ray was normal. Three sets of blood cultures
Ž .were obtained. A computed tomography CT head
scan showed a right parietal lobe hypodense lesion
without mass effect suggestive of an intracranial col-
Ž .lection. Cerebrospinal fluid CSF analysis showed
6 Ž 6.20010 l leukocytes 510 with 96% neu-
6 Ž 6.trophils, 510 l erythrocytes 510 , no bacte-
Ž .ria on Gram stain, glucose 4.7 mmoll 2.55.0 and
Ž .protein 870 mgl 150600 . Further testing for en-
capsulated yeast-like cells, cryptococcal antigen and
acid-fast bacilli was negative. There was no growth
on CSF culture after 14 days.
Intravenous ceftriaxone and flucloxacillin was com-
menced. Blood cultures grew a pure growth of
Staphylococcus aureus within 24 hours, and a final
diagnosis of staphylococcal bacterial endocarditis of
Žthe mitral valve vegetations seen on trans-
.oesophageal echocardiography with septic embolic
infarction of the brain was made. The patient eventu-
ally made a full recovery.
DISCUSSION
Even though symptoms of ciguatera poisoning were
described by European explorers to the New World
as early as the 16th century,6 the term ciguatera is
credited to F. Poey, an ichthyologist who observed
the similarity between symptoms of ciguatera poison-
ing and an illness caused by a land mollusc or ‘cigua’
in 1866.3 Captain James Cook and his crew suffered
ciguatoxicity in the New Hebrides in 1776 after eat-
ing red bass.4
Queensland, where most ciguatera cases in Australia
occur, released clinical details of 617 cases from 225
outbreaks over 23 years in 1988.11 Major outbreaks
tend to be sporadic and localized,1,10 occurring in
travellers returning from ciguatera-endemic areas or
with the consumption of contaminated imported
fish.6,12,13 Although more than 400 fish species are
potential vectors,1,6 fish caught along the tropical
coast of Australia such as narrow-barred mackerel
Ž . ŽScomberomorus commersoni , barracuda Sphyraena
. Ž .jello and coral trout Plectropomus spp. are most
often implicated.8 Large reef fish of more than 3
kilograms from ‘at risk’ areas are more susceptible
due to the concentration of toxin up the food
chain.5,6,14 It is advisable to avoid eating such fish
altogether to minimize exposure to ciguatera, or for 6
months after ciguatera poisoning to prevent a re-
lapse.1,5,6,14 Furthermore, sale and human consump-
tion of the moray eel, chinaman, red bass and paddle-
tail fishes, well recognized to be ciguatera prone, are
discouraged in Australia.7
Ciguatoxin is a lipid-soluble, heat stable polyether
toxin without colour, taste or smell produced by the
dinoflagellate Gambierdiscus toxicus found on
macroalgae in coral reefs. It is the most important of
20 toxins implicated in ciguatera poisoning.1,15 G.
toxicus is consumed by small herbivorous fish that
are eaten by larger fish that are consumed by hu-
mans. These toxins are progressively concentrated up
the food chain, being harmless to the fish host them-
selves.1,6,15
Typical features of ciguatera poisoning include acute
Žgastroenteritis nausea, vomiting, diarrhoea and ab-
.dominal pain within 612 hours of contaminated
fish ingestion. This is followed within 1272 hours by
characteristic neurocutaneous symptoms comprising
circumoral and limb paraesthesia, dysaesthesia and
pathognomonic paradoxical apparent temperature
sensation reversal. During this stage, musculoskeletal
features such as myalgia, arthralgia, cramps and
weakness as well as pruritus, sweating and dental
pain may be present.1,6 Although the acute illness
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lasts a mean of 8 days, neurological symptoms can
last for months and even years.5
Symptom severity is dose-dependent, with the inges-
tion of the fish’s head, liver or viscera causing more
severe poisoning as toxins are concentrated in these
tissues. Rarely, vasomotor dysregulation leading to
haemodynamic instability may precede paralysis and
coma. When recognized and treated early, death from
circulatory or respiratory failure occurs in less than
1% of cases.1,6,15 Symptoms worsen with alcohol con-
sumption, and can recur with future fish exposure,
even to non-ciguatoxic fish. The latter occurs at sub-
threshold toxin doses suggesting immunologically
mediated sensitization to ciguatoxin following an ini-
tial exposure.1,6,16
Although intravenous mannitol is considered the
most effective treatment for ciguatera poisoning, it
has not been directly compared with other agents in
controlled clinical trials.15  23 Its therapeutic effect was
discovered fortuitously in 1988, when two men who
became unconscious from severe ciguatera poisoning
responded within minutes after mannitol was admin-
istered for presumed cerebral oedema. A further 22
ciguatoxic patients had rapid relief of symptoms,
including one with circulatory failure.18 Since then,
case reports and treatment series from around the
world have reported success with the use of mannitol
in ciguatera poisoning, particularly when given early.
Five of 12 ciguatoxic adults in one series improved
with a 1.0 gkg infusion of mannitol.17 Neurological
symptoms responded well to mannitol in 14 of 16
patients in another series.20 Because mannitol is inex-
pensive, widely available and relatively easy to
administer, it is a suitable choice for the treatment of
ciguatera poisoning in isolated areas of the world
where ciguatera is endemic.16
An intravenous dose of 1 gkg of 20% mannitol
Ž .5 mlkg given over 30 minutes is recom-
mended.17,18,21  23 This dosing regimen is more effec-
tive than 0.5 gkg given over a longer period, with
smaller doses or slower infusion rates implicated in
treatment failures.17,19 Mannitol administered within
48 hours completely relieved symptoms in 35 cigua-
toxic patients.21 Although mannitol is more effective
when given early,15,16,18 a response has been seen in
patients who have been symptomatic for up to 8
weeks.21 Our case series reaffirms the efficacy of
intravenous mannitol in the treatment of ciguatera
poisoning, even as late as 7 days after fish ingestion
Ž .in Case 4 .
Repeating mannitol treatment to reduce persistent or
recurrent symptoms if there is an initial favourable
response has some merit.8,1517,19 A second 0.5 gkg
dose of mannitol was administered to three of four
subjects in our series with sustained benefit, with the
third subject unable to stay for a second treatment.
He relapsed without an apparent precipitant such as
alcohol use or further fish consumption. This obser-
vation supports the use of repeated doses of mannitol
to reduce the risk of ongoing ciguatoxic symptoms.15
It is unclear exactly how mannitol improves symp-
toms of ciguatera poisoning,15 although there are
several postulates. Mannitol may inhibit the cigua-
toxin-induced opening of neurone membrane sodium
channels,8,15,20 thereby reducing cellular excitability
and repetitive action potential generation.1 It neutral-
izes ciguatoxin17 and establishes osmotic grad-
ients that reduce ciguatoxin-induced perineural
oedema.16,19 Mannitol increases the dissociation of
ciguatoxin from its cell membrane binding site24 and
inhibits ciguatera cytotoxicity in cell bioassays in
vitro.25
Mannitol is safe to use in ciguatera poisoning, with
few side-effects reported.1,18 Correction of dehydra-
tion from vomiting and diarrhoea prior to its admin-
istration will ameliorate fluid losses from an osmotic
diuresis.17 One patient had brief postural presyncope
after treatment. However, the most common com-
plaint was discomfort at the infusion site. Due to its
hyperosmolarity, 20% mannitol causes venous irrita-
tion resulting in infusion site pain and throm-
bophlebitis. Dilution of mannitol and intravenous
lignocaine boluses does not satisfactorily relieve this
pain.
Extract from leaves of Argusia argent, a traditional
New Caledonian remedy, have been shown to be
effective in vitro.26 Certain local anaesthetic agents
may have the ability to inhibit sodium channels that
have been modified by ciguatoxin. Orally adminis-
tered tocainide safely alleviated ciguatoxic symptoms
in three adult males in a small open-label trial.27
Local anaesthetic agents prevent binding of cigua-
toxin molecules to their neuronal receptors but also
non-selectively block normal sodium channels in vitro
Ž .personal communication Professor R. Lewis .
Although promising, these agents have no proven
efficacy in humans.16 Non-proven therapies also in-
clude calcium gluconate, nifedipine, amitrypty-
line,6,15,28 and vitamin B .8 Symptomatic treatment12
includes analgesics for musculoskeletal symptoms,
antihistamines for pruritus3,15 as well as antiemetics
and antidiarrhoeals.29 Gastrointestinal charcoal de-
contamination remains speculative, with its use re-
commended in other non-infective fish and shellfish
poisonings.6
Our cases were unusual in that three of four subjects
had severe penile pain including on erection and
ejaculation. This has rarely been reported. Case 1
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supports the premise that ciguatoxin may be trans-
mitted in semen during sexual intercourse, with dys-
pareunia in an unaffected woman following inter-
course with her affected male partner having previ-
ously been reported.30 Geller 31 et al. encountered an
unaffected man in whom penile pain occurred after
intercourse with his symptomatic female partner.
Case 5 cautions against making the diagnosis of
ciguatera poisoning based on symptoms that imitate
previous episodes, in the presence of markers for
sepsis such as persistent fever, rising neutrophil
leukocytosis and other suggestive clinical and labora-
tory indices. The lack of a therapeutic response to
mannitol should also alert the clinician to a possible
alternative diagnosis. Apart from ciguatera, acute
gastroenteritis followed by neurologic symptoms may
be due to paralytic or neurotoxic shellfish poisoning,
scombroid and pufferfish toxicity, botulism,
enterovirus 7, toxidromes and in our case bacter-
aemia.6,15,32
Ciguatera poisoning remains under-recognized des-
pite being frequently encountered in Australia,1,8,14,17
leading to treatment delay or omission. Symptoms
may then become persistent and occasionally debili-
tating.16,33 Delayed or incorrect diagnosis is partly
attributable to the lack of confirmatory tests for
ciguatera poisoning in humans.1 As there is no vali-
dated diagnostic test for ciguatera poisoning in hu-
Ž .mans personal communication Professor R. Lewis ,
it remains a clinical diagnosis based on the presence
of early gastroenteritis after suspect fish ingestion
followed by neurocutaneous and musculoskeletal
symptoms. Clusters of humans affected in common
source outbreaks are easier to recognize.6,7,10,12
The effects of intraperitoneal injection of suspect fish
samples into mice was the first bioassay for ciguato-
xin34 and remains the most widely accepted measure
of ciguatoxin bioactivity.25,35 The response of domes-
tic cats to being fed suspect fish preceded the use of
the mongoose for this purpose in endemic areas.15,34
Animal testing takes days to complete and is not
useful in clinical management.
Immunologically based detection methods avoid ani-
mal welfare concerns inherent in animal testing.25 A
sheep anti-ciguatoxin IgG enzyme-linked immunoas-
say and more recently a monoclonal antibody mem-
brane immunobead assay to detect contaminated fish
may be used to monitor the fishing industry but has
no diagnostic application in humans.1,4,6 Further-
more, these tests demonstrate immunological cross-
reactivity with other fish polyethers, giving rise to
false positive results.36
The use of a cell bioassay that responds rapidly to the
sodium channel activating action of ciguatoxin in a
dose-dependent manner has been shown to correlate
well with mouse bioassays.25 Liquid chromatography
and mass spectrometry was used to detect Pacific
ciguatoxin-1 in the flesh of a large coral cod con-
sumed by 20 patients who subsequently developed
ciguatoxicity.37
Despite these advances, there is currently no marine
toxinological detection facility for public health
surveillance in Australia.1,14 An Australian National
Biotoxin Strategy is under development to better
coordinate public health surveillance and response to
Žciguatera and other marine toxins personal commu-
.nication Professor R. Lewis . The adverse impact of
ciguatera poisoning extends beyond health care into
the fishing industry. Fisheries are of great economic
importance in the Pacific Islands. Following ciguatera
outbreaks, damage occurs to the fishing industry,
trade and tourism. Human health suffers due to
reluctance to consume fish, a primary source of diet-
ary protein in this region. It is ironic that in some
Pacific locations, 90% of fish eaten is imported and
comes out of a can.28
CONCLUSION
Ciguatera poisoning remains a global toxinological
threat for fish eaters.1  6 Large numbers of inhabitants
are afflicted seasonally with consumption of local
ciguatera prone fish in endemic areas.28 Isolated and
small group common source outbreaks are frequently
encountered in Australia1,8,14,17 but less often in
Europe2 and North America.4,5 With imported con-
taminated fish becoming increasingly available to
consumers in non-endemic areas,1 ciguatera poison-
ing will become a greater public health issue.7 Trav-
ellers to endemic areas may develop symptoms on
returning to their homes.13 Clinicians in non-en-
demic areas will therefore encounter this condition
more frequently. Without a test to detect the presence
of ciguatoxin in humans,1 diagnosis is made clinically
by recognizing a characteristic constellation of symp-
toms and signs following consumption of suspect
fish. These include pathognomonic neurocutaneous
symptoms following acute gastroenteritis.1,6 When
correctly identified, ciguatera poisoning can be effec-
tively treated with intravenous mannitol.15  23 The
greater likelihood that sustained symptomatic relief
will occur with early treatment emphasizes the im-
portance of making the correct diagnosis early.15,16,18
There may be a therapeutic role for local anaesthet-
ics16,27 and traditional remedies such as leaves of
Argusia argent.26
Apart from ciguatera, acute gastroenteritis followed
by neurologic symptoms may be due to paralytic or
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neurotoxic shellfish poisoning, scombroid and
pufferfish toxicity, botulism, enterovirus 71, toxi-
dromes and in our case bacteraemia.6,15,32 Fever and
other markers for sepsis, muscle weakness and fea-
tures of histamine toxicity are not seen with ciguatera
poisoning. As there are no confirmatory tests for
ciguatera, the diagnosis is made by recognition of a
characteristic mixture of gastrointestinal, neurocuta-
neous and constitutional symptoms after the exclu-
sion of alternative diagnoses.
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